Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to $28.0 million.

  • Ascendis Pharma A's Interest & Investment Income fell 6817.36% to $28.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $127.7 million, marking a year-over-year decrease of 2732.58%. This contributed to the annual value of $128.8 million for FY2025, which is 37077.44% up from last year.
  • Ascendis Pharma A's Interest & Investment Income amounted to $28.0 million in Q4 2025, which was down 6817.36% from $7.1 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Interest & Investment Income ranged from a high of $88.0 million in Q4 2024 and a low of $174619.4 during Q2 2021
  • Over the past 5 years, Ascendis Pharma A's median Interest & Investment Income value was $29.2 million (recorded in 2025), while the average stood at $32.1 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Interest & Investment Income soared by 4336398.48% in 2022, and later tumbled by 9198.32% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Interest & Investment Income (Quarter) stood at $24.9 million in 2021, then crashed by 86.48% to $3.4 million in 2022, then surged by 1090.61% to $40.1 million in 2023, then skyrocketed by 119.22% to $88.0 million in 2024, then tumbled by 68.17% to $28.0 million in 2025.
  • Its Interest & Investment Income was $28.0 million in Q4 2025, compared to $7.1 million in Q3 2025 and $62.3 million in Q2 2025.